Ed Moran
Impact in
-
- Antibiotic Use and Resistance
- Neurology top 5%
- Long-Term Effects of COVID-19
Papers in
-
- COVID-19 Clinical Research Studies 4
- SARS-CoV-2 and COVID-19 Research 2
- Dermatological diseases and infestations 1
-
- Antibiotic Use and Resistance 3
- Co-authors
- Fergus Hamilton (6 shared papers)Samuel Gunning (2 shared papers)David Arnold (4 shared papers)James William Dodd (3 shared papers)Nick A. Maskell (3 shared papers)Anna J. Morley (2 shared papers)Marie Attwood (1 shared paper)Alan R. Noel (1 shared paper)
- Journals
- Thorax (3 papers)The Lancet Infectious Diseases (3 papers)Journal of Infection (2 papers)BMJ (1 paper)Journal of Allergy and Clinical Immunology (1 paper)
- Partner nations
- United KingdomIreland
In The Last Decade
Ed Moran
17 papers receiving 1.1k citations
Ed Moran's Hit Papers
Peers
Comparison fields: 5 of 90
- Applied Microbiology and Biotechnology 74
- Neurology 435
- Infectious Diseases 349
- General Dentistry 6
- Clinical Biochemistry 37
Countries citing papers authored by Ed Moran
This map shows the geographic impact of Ed Moran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ed Moran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ed Moran more than expected).
Fields of papers citing papers by Ed Moran
This network shows the impact of papers produced by Ed Moran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ed Moran. The network helps show where Ed Moran may publish in the future.
Co-authors
The 25 scholars most cited alongside Ed Moran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort Hit paper breakdown → | 2020 | 485 |
| 2 | 2018 | 134 | |
| 3 | 2020 | 64 | |
| 4 | 2021 | 63 | |
| 5 | 2015 | 62 | |
| 6 | 2021 | 62 | |
| 7 | 2021 | 55 | |
| 8 | 2020 | 47 | |
| 9 | 2009 | 38 | |
| 10 | 2022 | 37 | |
| 11 | 2023 | 33 | |
| 12 | 2021 | 30 | |
| 13 | 2020 | 28 | |
| 14 | 2020 | 14 | |
| 15 | 2021 | 2 | |
| 16 | 2016 | 1 | |
| 17 | 2016 | 1 | |
| 18 | 2017 | 1 | |
| 19 | 2016 | 0 | |
| 20 | 2016 | 0 |
About Ed Moran
Ed Moran is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology, Microbiology, Neurology and Epidemiology, having authored 21 papers that have together received 1.2k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (4 papers), Sepsis Diagnosis and Treatment (3 papers), Infection Control and Ventilation (3 papers), Antibiotic Use and Resistance (3 papers), Long-Term Effects of COVID-19 (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Streptococcal Infections and Treatments (1 paper) and Dermatological diseases and infestations (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (74 citations), Neurology (435 citations), Infectious Diseases (349 citations), General Dentistry (6 citations) and Clinical Biochemistry (37 citations). Ed Moran has collaborated with scholars based in United Kingdom and Ireland. Frequent co-authors include Fergus Hamilton, Samuel Gunning, David Arnold, James William Dodd, Nick A. Maskell, Anna J. Morley, Marie Attwood, Alan R. Noel, Jason Viner and Alice Milne. Their work appears in journals such as Thorax, The Lancet Infectious Diseases, Journal of Infection, BMJ and Journal of Allergy and Clinical Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.